Therapeutic Targeting of Hypoxia-A2-Adenosinergic Signaling to Improve the Outcomes Oxygen-Ventilated COVID-19 Patients

Time: 4:45 pm
day: Day Two


• Harnessing the A2A adenosine receptor axis to prevent oxygen-mediated exacerbation of inflammation in COVID-19 patients with acute respiratory distress syndrome

• Understanding the tissue-protecting role of hypoxia and adenosine in infectious diseases and COVID-19 and strategies to improve protocols of supplemental oxygenation